Mimedx Group Stock Price Prediction
| MDXG Stock | USD 6.33 0.15 2.31% |
Momentum 55
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.138 | EPS Estimate Next Quarter 0.085 | EPS Estimate Current Year 0.42 | EPS Estimate Next Year 0.245 | Wall Street Target Price 12.2 |
Using MiMedx hype-based prediction, you can estimate the value of MiMedx Group from the perspective of MiMedx response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards MiMedx using MiMedx's stock options and short interest. It helps to benchmark the overall future attitude of investors towards MiMedx using crowd psychology based on the activity and movement of MiMedx's stock price.
MiMedx Short Interest
A significant increase or decrease in MiMedx's short interest from the previous month could be a good indicator of investor sentiment towards MiMedx. Short interest can provide insight into the potential direction of MiMedx stock and how bullish or bearish investors feel about the market overall.
200 Day MA 6.9139 | Short Percent 0.0389 | Short Ratio 5.9 | Shares Short Prior Month 4.4 M | 50 Day MA 7.051 |
MiMedx Group Hype to Price Pattern
Investor biases related to MiMedx's public news can be used to forecast risks associated with an investment in MiMedx. The trend in average sentiment can be used to explain how an investor holding MiMedx can time the market purely based on public headlines and social activities around MiMedx Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of MiMedx's market sentiment to its price can help taders to make decisions based on the overall investors consensus about MiMedx.
MiMedx Implied Volatility | 1.57 |
MiMedx's implied volatility exposes the market's sentiment of MiMedx Group stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if MiMedx's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that MiMedx stock will not fluctuate a lot when MiMedx's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in MiMedx to buy its stock at a price that has no basis in reality. In that case, they are not buying MiMedx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MiMedx after-hype prediction price | USD 6.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out MiMedx Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MiMedx After-Hype Price Prediction Density Analysis
As far as predicting the price of MiMedx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MiMedx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MiMedx, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MiMedx Estimiated After-Hype Price Volatility
In the context of predicting MiMedx's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MiMedx's historical news coverage. MiMedx's after-hype downside and upside margins for the prediction period are 3.80 and 8.88, respectively. We have considered MiMedx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MiMedx is somewhat reliable at this time. Analysis and calculation of next after-hype price of MiMedx Group is based on 3 months time horizon.
MiMedx Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as MiMedx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MiMedx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MiMedx, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.57 | 0.13 | 0.10 | 18 Events / Month | 7 Events / Month | In about 18 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
6.33 | 6.34 | 0.16 |
|
MiMedx Hype Timeline
MiMedx Group is now traded for 6.33. The entity has historical hype elasticity of 0.13, and average elasticity to hype of competition of 0.1. MiMedx is anticipated to increase in value after the next headline, with the price projected to jump to 6.34 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 0.16%, whereas the daily expected return is now at -0.16%. The volatility of related hype on MiMedx is about 391.77%, with the expected price after the next announcement by competition of 6.43. The company reported the previous year's revenue of 348.88 M. Net Income was 42 M with profit before overhead, payroll, taxes, and interest of 322.58 M. Given the investment horizon of 90 days the next anticipated press release will be in about 18 days. Check out MiMedx Basic Forecasting Models to cross-verify your projections.MiMedx Related Hype Analysis
Having access to credible news sources related to MiMedx's direct competition is more important than ever and may enhance your ability to predict MiMedx's future price movements. Getting to know how MiMedx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MiMedx may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INVA | Innoviva | 0.23 | 8 per month | 1.15 | 0.04 | 4.32 | (2.62) | 15.63 | |
| SANA | Sana Biotechnology | 0.24 | 8 per month | 4.99 | 0.04 | 13.56 | (9.19) | 43.34 | |
| DNTH | Dianthus Therapeutics | 1.67 | 8 per month | 0.00 | (0.03) | 5.38 | (5.14) | 19.54 | |
| NKTR | Nektar Therapeutics | (0.55) | 10 per month | 0.00 | (0.08) | 7.00 | (7.77) | 20.50 | |
| ATAI | ATAI Life Sciences | (0.10) | 9 per month | 0.00 | (0.09) | 8.37 | (8.05) | 32.85 | |
| RAPP | Rapport Therapeutics Common | 0.50 | 10 per month | 3.66 | (0.02) | 5.76 | (6.76) | 16.72 | |
| TSHA | Taysha Gene Therapies | 1.71 | 28 per month | 4.05 | 0.10 | 10.03 | (7.14) | 63.54 | |
| INBX | Inhibrx Biosciences | 3.04 | 9 per month | 4.11 | 0.13 | 7.03 | (7.23) | 112.80 | |
| SNDX | Syndax Pharmaceuticals | (0.29) | 11 per month | 2.46 | 0.1 | 8.88 | (5.07) | 18.09 | |
| CVAC | CureVac NV | 0.11 | 9 per month | 0.00 | (0.12) | 3.33 | (2.80) | 18.10 |
MiMedx Additional Predictive Modules
Most predictive techniques to examine MiMedx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MiMedx using various technical indicators. When you analyze MiMedx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MiMedx Predictive Indicators
The successful prediction of MiMedx stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MiMedx Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MiMedx based on analysis of MiMedx hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MiMedx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MiMedx's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 6.04 | 8.11 | 7.3 | 7.66 | Days Of Inventory On Hand | 140.44 | 144.65 | 130.18 | 100.02 |
Story Coverage note for MiMedx
The number of cover stories for MiMedx depends on current market conditions and MiMedx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MiMedx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MiMedx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MiMedx Short Properties
MiMedx's future price predictability will typically decrease when MiMedx's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MiMedx Group often depends not only on the future outlook of the potential MiMedx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MiMedx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 149 M | |
| Cash And Short Term Investments | 104.4 M |
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |